Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Delivering a healthier urban food environment
Donate
Standalone grabs with Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial
15/04/2019
